Divine Aleru

Divine Aleru, Microbiome Signatures Research Coordinator

About

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

Recent Posts

2026-01-07

The Mismetallation of Enzymes during Oxidative Stress

This study explores the effects of oxidative stress on metallation in E. coli enzymes, focusing on the competition between iron, zinc, and manganese for enzyme binding sites, and the protective role of manganese in restoring enzyme activity.

2026-01-07

Metal Preferences and Metallation

The study investigates the metal preferences and metallation processes of enzymes, particularly focusing on the role of metal ions in metalloenzyme function. It explores how cells regulate the binding of metals to enzymes and how these metals impact enzymatic activity. The study also delves into the competitive nature of metal ions such […]

2026-01-07

The Role of Metal Ions in Enzyme Catalysis and Human Health

This study investigates the role of metal ions in enzyme catalysis and their implications for human health. It specifically looks at the biochemical roles of essential metal ions, such as zinc, magnesium, iron, copper, and manganese, in various enzymatic processes. These ions are vital cofactors for numerous metalloenzymes that facilitate catalytic reactions, […]

2026-01-07

Metallation and mismetallation of iron and manganese proteins in vitro and in vivo: the class I ribonucleotide reductases as a case study

The study focuses on the metallation and mismetallation of iron and manganese proteins, with specific attention to class I ribonucleotide reductases (RNRs). The research explores the challenges organisms face when inserting the correct metal into proteins that require them for biological function. These enzymes are important for deoxynucleotide production in both eukaryotes […]

2026-01-05

Functional Shielding

Functional shielding describes the body’s active, layered defenses that prevent harm without relying solely on “walls” like skin or mucus. On a clinical level, the microbiome is central to this concept because it behaves like a living protective system: it limits pathogen growth through competitive exclusion, shapes local immune readiness, and generates metabolites that reinforce epithelial integrity. In the gut, colonization resistance emerges from a mix of nutrient competition, antimicrobial production, bile-acid transformation, and short-chain fatty acid signaling that supports tight junctions and antimicrobial peptide expression. When this shield is disrupted, most notably after broad-spectrum antibiotics, opportunists such as Clostridioides difficile can expand, illustrating how loss of microbial protection translates into disease risk.

2026-01-05

Probiotic supplementation – does it prevent or cause neonatal sepsis?

This review evaluates probiotic supplementation in preterm infants, showing strong evidence for reduced necrotizing enterocolitis and mortality, minimal impact on late-onset sepsis, and a low but real risk of probiotic-associated infection when gut integrity is compromised.

2026-01-05

Biology of Oral Streptococci

This review explains how oral streptococci shape biofilm formation, regulate microbial balance, and influence oral and systemic health through niche-specific adaptations.

2026-01-05

Staphylococcus epidermidis and its dual lifestyle in skin health and infection

This review explains how Staphylococcus epidermidis supports skin immunity and barrier function while also acting as a leading opportunistic pathogen. Strain diversity, host context, and microbial interactions determine whether it protects against disease or contributes to inflammation, biofilm infections, and antibiotic resistance.

2026-01-05

Butyrate’s role in human health

This review explains how microbiota-derived butyrate supports gut barrier function, immune balance, and metabolic health, and why restoring microbial butyrate production is critical for treating gastrointestinal disease.